Complication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 36, Issue 1, 2013, Pages 12-19

  Wernicke, A Gabriella ^a   Shamis, Michael ^c   Sidhu, Kulbir K ^d   Turner, Bruce C ^d   Goltser, Yevgenyia ^f   Khan, Imraan ^b   Christos, Paul J ^a   Komarnicky Kocher, Lydia T ^e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c Saint George University   (United States)

^d THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^e DREXEL UNIVERSITY   (United States)

^f BRANDEIS UNIVERSITY   (United States)

Author keywords

axillary lymph node dissection; axillary web syndrome; breast cancer; complication rates; decreased range of motion; lymphedema; paresthesia; radiotherapy; sentinel lymph node; seroma

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; AXILLARY WEB SYNDROME; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; COMPLICATION; DECREASED RANGE OF MOTION OF THE IPSILATERAL SHOULDER; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; PARESTHESIA; PARTIAL MASTECTOMY; PATIENT ASSESSMENT; PROTEIN EXPRESSION; SELF EVALUATION; SEROMA; TUMOR LOCALIZATION; TUMOR VOLUME; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; TIME FACTORS; YOUNG ADULT;

EID: 84872902738     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3182354bda     Document Type: Article

References (47)

1. Zackrisson S, Janzon L, Manjer J, et al. Improved survival rate for women with interval breast cancer-results from breast cancer screening programme in Malmo, Sweden 1976-1999. J Med Screen. 2007;14:138-143
2. Smigal C, Jemal A, Ward E, et al. Trends in breast cancer by race and ethnicity: Update 2006. CA Cancer J Clin. 2006;56:168-183 (Pubitemid 43847927)
3. van Deurzen CH, Seldenrijk CA, Koelemij R, et al. The microanatomic location of metastatic breast cancer in sentinel lymph nodes predicts nonsentinel lymph node involvement. Ann Surg Oncol. 2008;15:1309-1315
4. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241 (Pubitemid 35176242)
5. Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567-575
6. Veronesi U, Galimberti V, Paganelli G, et al. Axillary metastases in breast cancer patients with negative sentinel nodes: A follow-up of 3548 cases. Eur J Cancer. 2009;45:1381-1388
7. Chadha M, Mehta P, Feldman S, et al. Intraopertive high-dose-rate brachytherapy - a novel technique in the surgical management of axillary recurrence. Breast Journal. 2009;15:140-145
8. Veronesi U, Paganelli G, Viale G, et al. Randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546-553 (Pubitemid 36951366)
9. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349:1864-1867 (Pubitemid 27270119)
10. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-398; 398-401 (Pubitemid 24313232)
11. Wernicke AG, Goodman RL, Turner BC, et al. 10 year follow up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance. Breast Cancer Res Treat. 2010;125:893-902
12. Erb K, Julian T. Completion of axillary dissection for a positive sentinel node: Necessary or not? Curr Oncol Rep. 2009;11:15-20
13. Ashikaga T, Krag D, Land S, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axiallary dissection. J Surg Oncol. 2010;102:111-118
14. Alvarez R. Present and future evolution of advanced breast cancer therapy. Breast Cancer Res. 2010;12(suppl 2):S1
15. Njeh C, Saunders M, Langton C. Accelerated partial breast irradiation (APBI): A review of available techniques. Radiat Oncol. 2010;5:90
16. Pleijhuis R, Graafland M, Vreis J, et al. Obtaining Adequate surgical margins in breast-conserving therapy for patients with early -stage breast cancer: Current modalities and future directions. Ann Surg Oncol. 2009;16:2717-2730
17. Hernanz F, Santos R, Arruabarrena A, et al. Treatment of symptomatic macromastia in a breast unit. World J Surg Oncol. 2010;8:93
18. Bitencourt A, Lima E, Pinto P, et al. New applications of radioguided surgery in oncology. Clinics. 2009;64:397-402
19. Ridings P, Bailey C, Bucknall TE. Argon beam coagulation as an adjunct in breast-conserving surgery. Ann R Coll Surg Engl. 1998;80:61-62 (Pubitemid 28043662)
20. Gipponi M, Bassetti C, Canavese G, et al. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. J Surg Oncol. 2004;85:102-111 (Pubitemid 38313932)
21. Hannoun-Levi JM, Castelli J, Plesu A, et al. Second conservative treatment for ipsilateral breast cancer recurrence using high-dose rate interstitial brachytherapy: Preliminary clinical results and evaluation of patient satisfaction. Brachytherapy. 2011;10: 171-177
22. Sanghani M, Balk E, Cady B. Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients. A systematic review and meta-analysis. American Cancer Society. 2009;115:1613-1620
23. Guilliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel lymph node metastasis. JAMA. 2011;305:569-575
24. Autier P, Boniol M, LaVecchia C, et al. Disparities in breast cancer mortality trends between 30 European countries: Retrospective trend analysis of WHO mortality database. BMJ. 2010;341:c3620
25. Aareleid T, Brenner H. Trends in cancer patient survival in Estonia before and after the transition from a Soviet Republic to an openmarket economy. Int J Cancer. 2002;102:45-50
26. Lucci A, McCall L, Beitsch P, et al. Surgical complication associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American college of surgeons oncology group trial Z0011. J Clin Oncol. 2007;25:3657-3663 (Pubitemid 47372604)
27. McLaughlin S, Wright M, Morris K, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: Patient perceptions and precautionary behaviors. J Clin Oncol. 2008;26:5220-5226
28. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer. ALMANIC Trial J Natl Cancer Inst. 2006;98:599-609 (Pubitemid 43904843)
29. Land S, Kopec J, Julian T, et al. Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project Phase III Protocol B-32. J Clin Oncol. 2010;28:3929-3936
30. Zavagno G, De Salvo G, Scalco G, et al. randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer. Ann Surg. 2008;247:207-213 (Pubitemid 351156760)
31. Johansson K, Branje E. Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis. Acta Oncol. 2010; 49:166-173
32. Leduc O, Sichere M, Moreau A, et al. Axillary web syndrome: Nature and localization. Lymphology. 2009;42:176-181
33. Moskovitz A, Anderson B, Yeung R, et al. Axillary web syndrome after axillary dissection. Am J Surg. 2001;181:434-439 (Pubitemid 32614112)
34. Reedijk M, Boerner S, Ghazarian D, et al. A case of axillary web syndrome with subcutaneous nodules following axillary surgery. Breast. 2006;15:411-413
35. Aydogan F, Korkut BA, Baghaki S, et al. Axillary web syndrome after sentinel node biopsy. Breast Care. 2008;3:277-278
36. Leidenius M, Leppa?nen E, Krogerus L, et al. Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg. 2003;185:127-130 (Pubitemid 36143900)
37. Lacomba MT, delMoral OM, Zazo JLC, et al. Axillary web syndrome after axillary dissection in breast cancer: A prospective study. Breast Cancer Res Treat. 2009;117:625-630
38. Goodman RL, Grann A, Saracco P, et al. The relationship between radiation fields and regional lymph nodes in carcinoma of the breast. Int J Radiat Oncol Biol Phys. 2001;50:99-105
39. Smitt M, Goffinet D. Utility of three-dimensional planning for axillary node coverage with breast-conserving radiation therapy: Early experience. Radiology. 1999;210:221-226 (Pubitemid 29004308)
40. Takeda A, Shigematsu N, Kondo M, et al. The modified tangential irradiation technique for breast cancer: How to cover the entire axillary region. Int J Radiat Oncol Biol Phys. 2000;46:815-822 (Pubitemid 30114392)
41. Krasin M, McCall A, King S, et al. Evaluation of a standard breast tangent technique: A dose-volume analysis of tangential irradiation using three-dimensional tools. Int J Radiat Oncol Biol Phys. 2000;47:327-333 (Pubitemid 30236372)
42. Aristei C, Chionne F, Marsella A, et al. Evaluation of level I and II axillary nodes included in the standard breast tangential fields and calculation of the administered dose: Results of a prospective study. Int J Radiat Oncol Biol Phys. 2001;51:69-73 (Pubitemid 32758863)
43. Schlembach PJ, Buchholz TA, Ross MI, et al. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys. 2001;51:671-678
44. Takeda A, Shigematsu N, Ikeda T, et al. Evaluation of novel modified tangential irradiation technique for breast cancer patients using dose-volume histograms. Int J Radiat Oncol Biol Phys. 2004;58:1280-1288 (Pubitemid 38314814)
45. Orecchia R, Huscher A, Leonardi MC, et al. Irradiation with standard tangential breast fields in patients treated with conservative surgery and sentinel node biopsy: Using a threedimensional tool to evaluate the first level coverage of the axillary nodes. Br J Radiol. 2005;78:51-54 (Pubitemid 40277138)
46. Wong JS, Taghian AG, Bellon JR, et al. Tangential radiotherapy without axillary surgery in early-stage breast cancer: Results of a prospective trial. Int J Radiat Oncol Biol Phys. 2008;72:866-870
47. Rabinovitch R, Ballonoff A, Newman F, et al. Evaluation of breast sentinel lymph node coverage by standard radiation therapy fields. Int J Radiat Oncol Biol Phys. 2008;70:1468-1471 (Pubitemid 351417768)